Wellcome and goodbye

February 27, 1998

This week's alumnus to be proud of, No 160 in the series, knows a little about educational quality. Sir Richard Sykes took a first in microbiology at Queen Elizabeth College, London, and a PhD in microbial chemistry at Bristol.

More recently, as chairman of Glaxo Wellcome, he plotted the formation of the world's biggest drugs company with plans to merge with SmithKline Beecham. The plans are off, after a tiff about which of the top dogs would get which big job. So perhaps Sir Richard now has enough free time to resume the membership of the QAA which he resigned in January due to pressure of work.

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments

Have your say

Log in or register to post comments

Most Commented

James Fryer illustration (27 July 2017)

It is not Luddism to be cautious about destroying an academic publishing industry that has served us well, says Marilyn Deegan

Hand squeezing stress ball
Working 55 hours per week, the loss of research periods, slashed pensions, increased bureaucracy, tiny budgets and declining standards have finally forced Michael Edwards out
Jeffrey Beall, associate professor and librarian at the University of Colorado Denver

Creator of controversial predatory journals blacklist says some peers are failing to warn of dangers of disreputable publishers

Kayaker and jet skiiers

Nazima Kadir’s social circle reveals a range of alternative careers for would-be scholars, and often with better rewards than academia

hole in ground

‘Drastic action’ required to fix multibillion-pound shortfall in Universities Superannuation Scheme, expert warns